BlackRock Investment Management, LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 37 filers reported holding CANCER GENETICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2016$3,000
-25.0%
2,0860.0%0.00%
Q3 2016$4,0000.0%2,0860.0%0.00%
Q2 2016$4,0000.0%2,086
+46.5%
0.00%
Q1 2016$4,000
+33.3%
1,424
+35.9%
0.00%
Q4 2015$3,000
-62.5%
1,0480.0%0.00%
Q3 2015$8,000
-33.3%
1,0480.0%0.00%
Q2 2015$12,000
+50.0%
1,0480.0%0.00%
Q1 2015$8,000
+14.3%
1,048
-4.1%
0.00%
Q4 2014$7,000
-30.0%
1,0930.0%0.00%
Q3 2014$10,000
-9.1%
1,093
+10.0%
0.00%
Q2 2014$11,0009940.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 22,203$148,0002.90%
Millrace Asset Group, Inc. 187,184$1,250,0001.30%
Sterneck Capital Management, LLC 60,650$405,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$560,0000.15%
Quality Growth Management, Inc. 23,500$157,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$334,0000.05%
DIKER MANAGEMENT LLC 35,015$234,0000.05%
SSI INVESTMENT MANAGEMENT LLC 65,043$434,0000.04%
BANK OF MONTREAL /CAN/ 616,430$4,118,0000.01%
Commonwealth Equity Services, Inc 27,100$181,0000.00%
View complete list of CANCER GENETICS INC shareholders